Why the first copy of a biological approved under the European biosimilar pathway was growth hormone

Published 26 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
The European Medicines Agency approved Omnitrope, a recombinant somatropin, in April 2006 as the first product under its biosimilar pathway, with the United States following for the same product later that year under an older provision. A biosimilar is a biological shown to be highly similar to an approved reference product in structure, purity, activity and clinical performance, rather than identical as a generic small molecule would be. Growth hormone was the natural first case: a well-characterised, non-glycosylated protein with decades of clinical data and clear markers of effect.

Why not a generic

A small molecule can be shown identical by chemistry. A protein made in cells carries variation in folding, modification and impurity profile that depends on the process, so two somatropins from two processes are similar but not provably identical. The biosimilar framework requires an extensive comparability exercise — analytical, functional, pharmacological and clinical — to show the differences do not matter.

Somatropin, being unglycosylated and small for a protein, made that exercise tractable.

What comparability covers

Primary structure by peptide mapping and mass; higher-order structure by spectroscopy; related proteins, aggregates and charge variants side by side with the reference; receptor binding and cell-based potency; pharmacokinetics; and clinical equivalence in growth velocity. Each is the same test a single manufacturer runs on its own lots, applied across two products.

The methods are those described on the analytical pages here.

Why it matters

Several somatropins are now on the market as biosimilars, and the framework they established governs every copy of a biological since. The pack in this catalogue is research-grade somatropin and is not a biosimilar or any approved product.

Somatropin is supplied by REVIVE LAB UAE for laboratory research use only, with identity and purity documented for the batch. It is not for human or veterinary use, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
HGH Somatropin Pack24 mg (72 IU)AED 850In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

Why not a generic?

A small molecule can be shown identical by chemistry. A protein made in cells carries variation in folding, modification and impurity profile that depends on the process, so two somatropins from two processes are similar but not provably identical. The biosimilar framework requires an extensive comparability exercise — analytical, functional, pharmacological and clinical — to show the differences do not matter.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

HGH Somatropin Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.